icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
Effectiveness of therapy in 16,567 directly-acting antiviral treated people in England: high response rates in genotype 3 hepatitis C infection regardless of degree of fibrosis, but ribavirin improves response in cirrhosis
  Reported by Jules Levin
EASL 2019 April 10-14 Vienna
Kate Drysdale1, Ceri Townley2, Faizel Mahomed3, Graham Foster1
1Barts Liver Centre, The Blizard Institute, Queen Mary University of London, London, United Kingdom;
2NHS England, Specialised Services National Support Team, Southampton, United Kingdom; 3NHS
Arden and Greater East Midlands Commissoning Support Unit, Leicester, United Kingdom